Literature DB >> 12181650

Transformation of interstitial fibroblasts and tubulointerstitial fibrosis in diabetic nephropathy.

Keisuke Ina1, Hirokazu Kitamura, Shuji Tatsukawa, Tetsuya Takayama, Yoshihisa Fujikura, Tatsuo Shimada.   

Abstract

The developmental mechanism of tubulointerstitial fibrosis in diabetic nephropathy (DN) has not been elucidated. Tubulointerstitial fibrosis, as well as glomerulosclerosis, occurs in DN. Myofibroblasts which overproduce extracellular matrix are present in the renal interstitium in diabetics, although they are almost never seen in normal kidneys. The myofibroblasts appear to originate from interstitial fibroblasts. In addition, transforming growth factor-beta1 (TGF-beta 1), which can evoke myofibroblast transformation, is detected in interstitial cells in the diabetic kidney, but not in the normal kidney. Taken together, these findings led us to speculate that TGF-beta 1 induces the transformation of interstitial fibroblasts into myofibroblasts, followed by tubulointerstitial fibrosis. Based on this speculation, we discuss the developmental mechanism of tubulointerstitial fibrosis in this review.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12181650     DOI: 10.1007/s007950200011

Source DB:  PubMed          Journal:  Med Electron Microsc        ISSN: 0918-4287


  19 in total

1.  Characterisation of myofibroblasts in fibrovascular tissues of primary and recurrent pterygia.

Authors:  A Touhami; M A Di Pascuale; T Kawatika; M Del Valle; R H Rosa; S Dubovy; S C G Tseng
Journal:  Br J Ophthalmol       Date:  2005-03       Impact factor: 4.638

2.  ANGPTL2 regulates autophagy through the MEK/ERK/Nrf-1 pathway and affects the progression of renal fibrosis in diabetic nephropathy.

Authors:  Haiquan Huang; Haifeng Ni; Kunling Ma; Jihong Zou
Journal:  Am J Transl Res       Date:  2019-09-15       Impact factor: 4.060

3.  Aquaporin 11 variant associates with kidney disease in type 2 diabetic patients.

Authors:  David P Choma; Roberto Vanacore; Helen Naylor; Ian A Zimmerman; Andrei Pavlichenko; Artyom Pavlichenko; Liberty Foye; David P Carbone; Raymond C Harris; Mikhail M Dikov; Elena E Tchekneva
Journal:  Am J Physiol Renal Physiol       Date:  2015-12-30

Review 4.  Fibroblasts and myofibroblasts in renal fibrosis.

Authors:  Soma Meran; Robert Steadman
Journal:  Int J Exp Pathol       Date:  2011-02-28       Impact factor: 1.925

5.  Salutary effects of a novel oxidative stress modulator on adenine-induced chronic progressive tubulointerstitial nephropathy.

Authors:  Susanne B Nicholas; Jun Yuan; Amin Aminzadeh; Keith C Norris; Albert Crum; Nosratola D Vaziri
Journal:  Am J Transl Res       Date:  2012-07-20       Impact factor: 4.060

6.  17beta-Estradiol attenuates diabetic kidney disease by regulating extracellular matrix and transforming growth factor-beta protein expression and signaling.

Authors:  Alexis Dixon; Christine Maric
Journal:  Am J Physiol Renal Physiol       Date:  2007-08-08

7.  Renoprotective action of a matrix metalloproteinase inhibitor in progressive mesangioproliferative nephritis.

Authors:  Takayuki Kuroda; Masao Masui; Mitsuru Notoya; Masashi Ito; Yoshinori Tamura; Hiroyuki Okamoto; Eri Kanaoka; Toshihiro Shinosaki
Journal:  Nephron Extra       Date:  2012-05-26

8.  Contraction of tubulointerstitial fibrosis tissue in diabetic nephropathy, as demonstrated in an in vitro fibrosis model.

Authors:  Keisuke Ina; Hirokazu Kitamura; Shuji Tatsukawa; Takashi Miyazaki; Hirokazu Abe; Yoshihisa Fujikura
Journal:  Virchows Arch       Date:  2007-09-25       Impact factor: 4.535

Review 9.  The renal cortical interstitium: morphological and functional aspects.

Authors:  Brigitte Kaissling; Michel Le Hir
Journal:  Histochem Cell Biol       Date:  2008-06-25       Impact factor: 4.304

Review 10.  The myofibroblast: phenotypic characterization as a prerequisite to understanding its functions in translational medicine.

Authors:  B Eyden
Journal:  J Cell Mol Med       Date:  2007-12-22       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.